CVX Vs XOM Stock, Which Energy Play Is Best?
Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…
Buy
56
MCY Quote, Financials, Valuation and Earnings
Last price:
$56.92
Seasonality move
:
1.82%
Day range:
$58.07 - $59.26
52-week range:
$44.19 - $80.72
Dividend yield:
2.15%
P/E ratio:
6.98x
P/S ratio:
0.60x
P/B ratio:
1.68x
Volume:
723.3K
Avg. volume:
383.4K
1-year change:
5.06%
Market cap:
$3.3B
Revenue:
$5.5B
EPS (TTM):
$8.45
Mercury General Number of Institutional Trades
Mercury General Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$1.3B
(Last 6 Months)
Current Institutional Ownership Percentage
65.5%
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$1.6B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Mercury General Institutional Ownership
-
What Percentage Of MCY Is Owned by Institutions?
65.5% of MCY is owned by institutions.
-
How Many Institutions Own MCY Shares?
Mercury General stock is owned by 542 institutional shareholders at this time.
-
Have Institutions Been Buying MCY Stock?
Yes, institutions have bought 13.2M shares of MCY in the last quarter.
-
Have Institutions Been Selling MCY Stock?
Yes, institutions have sold 15.5M shares of MCY over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is it Safe to Invest in Google With OpenAI Threats?
For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…
Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 7
Regencell Bioscience Holdings [RGC] is up 22.52% over the past day.
Buy
77
FARO alert for May 7
Faro Technologies [FARO] is down 0% over the past day.
Buy
53
SRPT alert for May 7
Sarepta Therapeutics [SRPT] is down 21.54% over the past day.
